Catalyst Pharmaceuticals, Inc(NASDAQ:CPRX) 
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphat...
Website: http://www.catalystpharma.com
Founded: 2002
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 23.49
H 24.27
L 22.85
C 23.07
V 2,214,782
10EMA 23.07
20EMA 23.07
60EMA 23.07
120EMA 23.07
250EMA 23.07